Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT
Edwards Lifesciences Corp (EW) SEC filings
Edwards Lifesciences Corp (EW) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported EW revenue for 2025-12-31 was $6.07B. Net income was $1.07B. Revenue was up 1.0% from 2023-12-31 to 2025-12-31. EW currently screens at market cap $49.91B and trailing P/E 50.3. The EW filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Edwards Lifesciences Corp said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
Earnings & events
All eventsEvent insights for EW — what management said, what changed, and why it matters.
Recent filings
EW SEC filings FAQ
What is the latest EW SEC filing?
The latest cached Edwards Lifesciences Corp (EW) filing on this page is 8-K · Aug 28, 2026. Filings: https://lician.com/sec/ew
What is the latest EW filing accession number?
The latest cached Edwards Lifesciences Corp (EW) accession number on this page is 0001099800-26-000048. Filing: https://lician.com/sec/ew/0001099800-26-000048
Which item code is on the latest EW filing?
Cached item code on the latest Edwards Lifesciences Corp (EW) 8-K is 5.02.
How many EW SEC filings are listed on this page?
This page lists 2 cached Edwards Lifesciences Corp (EW) SEC filings. Filings: https://lician.com/sec/ew
What events are listed on the EW SEC page?
Cached event headlines on this Edwards Lifesciences Corp (EW) SEC page: "EW earnings". Events: https://lician.com/sec/ew
What is EW's P/E ratio?
Edwards Lifesciences Corp (EW) trailing P/E is 50.3 on the latest cached fundamentals snapshot.
What are EW's latest revenue and net income?
Latest cached Edwards Lifesciences Corp (EW) revenue for Dec 31, 2025 was $6.07B. Net income was $1.07B. Statements: https://lician.com/financials/ew